BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreno E, Cavic M, Krivokuca A, Casadó V, Canela E. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? Front Pharmacol 2019;10:339. [PMID: 31024307 DOI: 10.3389/fphar.2019.00339] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Ko M, Breznik B, Senjor E, Jewett A. Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells. Advances in Cancer Biology - Metastasis 2022;5:100043. [DOI: 10.1016/j.adcanc.2022.100043] [Reference Citation Analysis]
2 Uranbileg B, Kurano M, Kano K, Sakai E, Arita J, Hasegawa K, Nishikawa T, Ishihara S, Yamashita H, Seto Y, Ikeda H, Aoki J, Yatomi Y. Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids. Clin Transl Med 2022;12:e1056. [PMID: 36125914 DOI: 10.1002/ctm2.1056] [Reference Citation Analysis]
3 Venn-Watson S, Reiner J, Jensen ED. Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health. Sci Rep 2022;12:13717. [PMID: 35999445 DOI: 10.1038/s41598-022-18266-w] [Reference Citation Analysis]
4 Punzo F, Argenziano M, Tortora C, Di Paola A, Mutarelli M, Pota E, Di Martino M, Di Pinto D, Marrapodi MM, Roberti D, Rossi F. Effect of CB2 Stimulation on Gene Expression in Pediatric B-Acute Lymphoblastic Leukemia: New Possible Targets. IJMS 2022;23:8651. [DOI: 10.3390/ijms23158651] [Reference Citation Analysis]
5 Amoroso R, De Lellis L, Florio R, Moreno N, Agamennone M, De Filippis B, Giampietro L, Maccallini C, Fernández I, Recio R, Cama A, Fantacuzzi M, Ammazzalorso A. Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure–Activity Relationship Studies and Target Prediction Analysis. Pharmaceuticals 2022;15:937. [DOI: 10.3390/ph15080937] [Reference Citation Analysis]
6 Behl T, Makkar R, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM, Bungau S. Exploration of Multiverse Activities of Endocannabinoids in Biological Systems. Int J Mol Sci 2022;23:5734. [PMID: 35628545 DOI: 10.3390/ijms23105734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Martínez-Peña AA, Petrik JJ, Hardy DB, Holloway AC. Delta-9-tetrahydrocannabinol increases vascular endothelial growth factor (VEGF) secretion through a cyclooxygenase-dependent mechanism in rat granulosa cells. Reprod Toxicol 2022:S0890-6238(22)00064-8. [PMID: 35588954 DOI: 10.1016/j.reprotox.2022.05.004] [Reference Citation Analysis]
8 Khunluck T, Lertsuwan K, Chutoe C, Sooksawanwit S, Inson I, Teerapornpuntakit J, Tohtong R, Charoenphandhu N. Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration. Sci Rep 2022;12:7398. [PMID: 35513484 DOI: 10.1038/s41598-022-11116-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shoeib AM, Benson LN, Mu S, MacMillan-Crow LA, Prather PL. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death. Int J Mol Sci 2022;23:3049. [PMID: 35328467 DOI: 10.3390/ijms23063049] [Reference Citation Analysis]
10 Sobiepanek A, Milner-krawczyk M, Musolf P, Starecki T, Kobiela T. Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells. Cancers 2022;14:1419. [DOI: 10.3390/cancers14061419] [Reference Citation Analysis]
11 Bailone RL, Fukushima HCS, de Aguiar LK, Borra RC. The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. Lab Anim Res 2022;38. [DOI: 10.1186/s42826-022-00116-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Emhemmed F, Zhao M, Yorulmaz S, Steyer D, Leitao C, Alignan M, Cerny M, Paillard A, Delacourt FM, Julien-David D, Muller CD. Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein. Molecules 2022;27:1214. [PMID: 35209003 DOI: 10.3390/molecules27041214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Honoré B, Andersen MD, Wilken D, Kamper P, d'Amore F, Hamilton-Dutoit S, Ludvigsen M. Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling. Cancers (Basel) 2022;14:247. [PMID: 35008410 DOI: 10.3390/cancers14010247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Boyacıoğlu Ö, Korkusuz P. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_748] [Reference Citation Analysis]
15 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Boullon L, Abalo R, Llorente-berzal Á. Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment. Front Pharmacol 2021;12:734613. [DOI: 10.3389/fphar.2021.734613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Gobbo F, Sarli G, De Silva M, Galiazzo G, Chiocchetti R, Morini M. A Double Histochemical/Immunohistochemical Staining for the Identification of Canine Mast Cells in Light Microscopy. Vet Sci 2021;8:229. [PMID: 34679059 DOI: 10.3390/vetsci8100229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M. A Proteomic View of Cellular and Molecular Effects of Cannabis. Biomolecules 2021;11:1411. [PMID: 34680044 DOI: 10.3390/biom11101411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Morin-Buote J, Ennour-Idrissi K, Poirier É, Lemieux J, Furrer D, Burguin A, Durocher F, Diorio C. Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients. J Pers Med 2021;11:852. [PMID: 34575629 DOI: 10.3390/jpm11090852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Singh K, Nassar N, Bachari A, Schanknecht E, Telukutla S, Zomer R, Piva TJ, Mantri N. The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. Cancers (Basel) 2021;13:4107. [PMID: 34439262 DOI: 10.3390/cancers13164107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Brown JD, Rivera Rivera KJ, Hernandez LYC, Doenges MR, Auchey I, Pham T, Goodin AJ. Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions. J Clin Pharmacol 2021;61 Suppl 2:S37-52. [PMID: 34396558 DOI: 10.1002/jcph.1871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Guidolin D, Tortorella C, Marcoli M, Cervetto C, Maura G, Agnati LF. Receptor-Receptor Interactions and Glial Cell Functions with a Special Focus on G Protein-Coupled Receptors. Int J Mol Sci 2021;22:8656. [PMID: 34445362 DOI: 10.3390/ijms22168656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Teodoro R, Gündel D, Deuther-Conrad W, Ueberham L, Toussaint M, Bormans G, Brust P, Moldovan RP. Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain. Int J Mol Sci 2021;22:8051. [PMID: 34360817 DOI: 10.3390/ijms22158051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH. Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol 2021;147:2507-34. [PMID: 34259916 DOI: 10.1007/s00432-021-03710-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
25 Morris G, Walder K, Kloiber S, Amminger P, Berk M, Bortolasci CC, Maes M, Puri BK, Carvalho AF. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks. Pharmacol Res 2021;170:105729. [PMID: 34119623 DOI: 10.1016/j.phrs.2021.105729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
26 Thomas A, Schultz C, Laguerre A. Incorporation of unnatural amino acid for the tagging of cannabinoid receptors 1 and 2 reveals receptor roles in regulating cAMP levels.. [DOI: 10.1101/2021.06.09.447758] [Reference Citation Analysis]
27 Ahmed I, Rehman SU, Shahmohamadnejad S, Zia MA, Ahmad M, Saeed MM, Akram Z, Iqbal HMN, Liu Q. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. Molecules 2021;26:3389. [PMID: 34205169 DOI: 10.3390/molecules26113389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
28 Braile M, Marcella S, Marone G, Galdiero MR, Varricchi G, Loffredo S. The Interplay between the Immune and the Endocannabinoid Systems in Cancer. Cells 2021;10:1282. [PMID: 34064197 DOI: 10.3390/cells10061282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
29 Jaiswal S, Ayyannan SR. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase. ChemMedChem 2021;16:2172-87. [PMID: 33834617 DOI: 10.1002/cmdc.202100120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Travers S, Litofsky NS. Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review. Brain Sci 2021;11:533. [PMID: 33922443 DOI: 10.3390/brainsci11050533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Lee DI, Murninkas M, Elyagon S, Etzion Y, Anderson HD. Cannabinoid Receptor Agonist Inhibits Atrial Electrical Remodeling in a Tachypaced Ex Vivo Rat Model. Front Pharmacol 2021;12:642398. [PMID: 33967775 DOI: 10.3389/fphar.2021.642398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gruber T, Robatel S, Kremenovic M, Bäriswyl L, Gertsch J, Schenk M. Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers (Basel) 2021;13:1934. [PMID: 33923757 DOI: 10.3390/cancers13081934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
34 Sedeighzadeh SS, Galehdari H, Tabandeh MR, Shamsara M, Roohbakhsh A, Capasso R. The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors. Mediators of Inflammation 2021;2021:1-9. [DOI: 10.1155/2021/6698049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Boyacıoğlu Ö, Bilgiç E, Varan C, Bilensoy E, Nemutlu E, Sevim D, Kocaefe Ç, Korkusuz P. ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro. Cell Death Dis 2021;12:56. [PMID: 33431819 DOI: 10.1038/s41419-020-03274-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Akimov MG, Gamisonia AM, Dudina PV, Gretskaya NM, Gaydaryova AA, Kuznetsov AS, Zinchenko GN, Bezuglov VV. GPR55 Receptor Activation by the N-Acyl Dopamine Family Lipids Induces Apoptosis in Cancer Cells via the Nitric Oxide Synthase (nNOS) Over-Stimulation. Int J Mol Sci 2021;22:E622. [PMID: 33435517 DOI: 10.3390/ijms22020622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
37 Bandyopadhayaya S, Akimov MG, Verma R, Sharma A, Sharma D, Kundu GC, Gretskaya NM, Bezuglov VV, Mandal CC. N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol. J Biochem Mol Toxicol 2021;35:e22693. [PMID: 33393692 DOI: 10.1002/jbt.22693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 de Lorimier L, Hazzah T, Amazonas E, Cital S. Cannabinoids in Oncology and Immune Response. Cannabis Therapy in Veterinary Medicine 2021. [DOI: 10.1007/978-3-030-68317-7_10] [Reference Citation Analysis]
39 Zhang H, Guo W, Zhang F, Li R, Zhou Y, Shao F, Feng X, Tan F, Wang J, Gao S, Gao Y, He J. Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma. Front Oncol 2020;10:559568. [PMID: 33363004 DOI: 10.3389/fonc.2020.559568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Lei X, Chen X, Quan Y, Tao Y, Li J. Targeting CYP2J2 to Enhance the Anti-Glioma Efficacy of Cannabinoid Receptor 2 Stimulation by Inhibiting the Pro-Angiogenesis Function of M2 Microglia. Front Oncol 2020;10:574277. [PMID: 33330047 DOI: 10.3389/fonc.2020.574277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Moreno E, Cavic M, Krivokuca A, Canela EI. The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment. Cancers (Basel) 2020;12:E3275. [PMID: 33167409 DOI: 10.3390/cancers12113275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
42 Laguerre A, Keutler K, Hauke S, Schultz C. Regulation of Calcium Oscillations in β-Cells by Co-activated Cannabinoid Receptors. Cell Chem Biol 2021;28:88-96.e3. [PMID: 33147441 DOI: 10.1016/j.chembiol.2020.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Morales P, Bruix M, Jiménez MA. Structural Insights into β-arrestin/CB1 Receptor Interaction: NMR and CD Studies on Model Peptides. Int J Mol Sci 2020;21:E8111. [PMID: 33143110 DOI: 10.3390/ijms21218111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Chu L, Liu W, Deng J, Wu Y, Yang H, Wang W, Hussain A, Li N, Zhou D, Deng H. Age-related changes in endogenous glucocorticoids, gonadal steroids, endocannabinoids and their ratios in plasma and hair from the male C57BL/6 mice. Gen Comp Endocrinol 2021;301:113651. [PMID: 33122035 DOI: 10.1016/j.ygcen.2020.113651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Mensching L, Rading S, Nikolaev V, Karsak M. Monitoring Cannabinoid CB2 -Receptor Mediated cAMP Dynamics by FRET-Based Live Cell Imaging. Int J Mol Sci 2020;21:E7880. [PMID: 33114208 DOI: 10.3390/ijms21217880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Mangiatordi GF, Intranuovo F, Delre P, Abatematteo FS, Abate C, Niso M, Creanza TM, Ancona N, Stefanachi A, Contino M. Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration. J Med Chem 2020;63:14448-69. [PMID: 33094613 DOI: 10.1021/acs.jmedchem.0c01357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
47 Haspula D, Clark MA. Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. Int J Mol Sci 2020;21:E7693. [PMID: 33080916 DOI: 10.3390/ijms21207693] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
48 Casati S, Giannasi C, Minoli M, Niada S, Ravelli A, Angeli I, Mergenthaler V, Ottria R, Ciuffreda P, Orioli M, Brini AT. Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by UHPLC-MS/MS. Biomolecules 2020;10:E1302. [PMID: 32917006 DOI: 10.3390/biom10091302] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
49 Ladha KS, Ajrawat P, Yang Y, Clarke H. Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence. Molecules 2020;25:E4042. [PMID: 32899678 DOI: 10.3390/molecules25184042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
50 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 28.5] [Reference Citation Analysis]
51 Zhai K, Shi XY, Yi FS, Huang ZY, Wu XZ, Dong SF, Wang W, Wu MT, Shi HZ. IL-10 promotes malignant pleural effusion by regulating TH 1 response via an miR-7116-5p/GPR55/ERK pathway in mice. Eur J Immunol 2020;50:1798-809. [PMID: 32506440 DOI: 10.1002/eji.202048574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Almogi-Hazan O, Or R. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int J Mol Sci 2020;21:E4448. [PMID: 32585801 DOI: 10.3390/ijms21124448] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
53 Mäder P, Bartholomäus R, Nicolussi S, Baumann A, Weis M, Chicca A, Rau M, Simão AC, Gertsch J, Altmann KH. Synthesis and Biological Evaluation of Endocannabinoid Uptake Inhibitors Derived from WOBE437. ChemMedChem 2021;16:145-54. [PMID: 32369259 DOI: 10.1002/cmdc.202000153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Meccariello R. Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives. Int J Mol Sci 2020;21:E3549. [PMID: 32443408 DOI: 10.3390/ijms21103549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
55 Forte D, Fanelli F, Mezzullo M, Barone M, Corradi G, Auteri G, Bartoletti D, Martello M, Ottaviani E, Terragna C, Curti A, Pagotto U, Palandri F, Cavo M, Catani L. Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms. Int J Mol Sci 2020;21:E3399. [PMID: 32403407 DOI: 10.3390/ijms21093399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 25.5] [Reference Citation Analysis]
57 Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle 2020;19:961-89. [PMID: 32249682 DOI: 10.1080/15384101.2020.1742952] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
58 Vago R, Ravelli A, Bettiga A, Casati S, Lavorgna G, Benigni F, Salonia A, Montorsi F, Orioli M, Ciuffreda P, Ottria R. Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage. Cancers (Basel) 2020;12:E870. [PMID: 32260109 DOI: 10.3390/cancers12040870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
59 Almogi-Hazan O, Khuja I, Ritter S, Or R. The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation. Rambam Maimonides Med J 2020;11. [PMID: 32017682 DOI: 10.5041/RMMJ.10391] [Reference Citation Analysis]
60 Laezza C, Pagano C, Navarra G, Pastorino O, Proto MC, Fiore D, Piscopo C, Gazzerro P, Bifulco M. The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci 2020;21:E747. [PMID: 31979368 DOI: 10.3390/ijms21030747] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 25.5] [Reference Citation Analysis]
61 Spinelli F, Giampietro R, Stefanachi A, Riganti C, Kopecka J, Abatematteo FS, Leonetti F, Colabufo NA, Mangiatordi GF, Nicolotti O, Perrone MG, Brea J, Loza MI, Infantino V, Abate C, Contino M. Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R). Eur J Med Chem 2020;188:112037. [PMID: 31954990 DOI: 10.1016/j.ejmech.2020.112037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
62 Ölgen S. Clinical trials on combination of repurposed drugs and anticancer therapies. Drug Repurposing in Cancer Therapy 2020. [DOI: 10.1016/b978-0-12-819668-7.00015-4] [Reference Citation Analysis]
63 Wouters E, Walraed J, Robertson MJ, Meyrath M, Szpakowska M, Chevigné A, Skiniotis G, Stove C. Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds. ACS Pharmacol Transl Sci 2020;3:285-95. [PMID: 32296768 DOI: 10.1021/acsptsci.9b00069] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
64 Wouters E, Walraed J, Banister SD, Stove CP. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology 2019;169:113623. [DOI: 10.1016/j.bcp.2019.08.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 16.3] [Reference Citation Analysis]
65 Melgar-Lesmes P, Perramon M, Jiménez W. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells 2019;8:E1311. [PMID: 31653030 DOI: 10.3390/cells8111311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
66 Steenson S, Chambers L. Cannabidiol: A budding industry! Nutr Bull 2019;44:228-40. [DOI: 10.1111/nbu.12395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Kleckner AS, Kleckner IR, Kamen CS, Tejani MA, Janelsins MC, Morrow GR, Peppone LJ. Opportunities for cannabis in supportive care in cancer. Ther Adv Med Oncol 2019;11:1758835919866362. [PMID: 31413731 DOI: 10.1177/1758835919866362] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]